Fidelity Value Strategies Fund
FSLSX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 245 Summer Street Boston MA United States of America 2210
- IPO Date
- Dec 30, 1983
- CIK
- 0000722574
- Website
- institutional.fidelity.com
- Similar Companies
- Business
- Fidelity Value Strategies Fund (FSLSX) is an open-end mutual fund managed by Fidelity Management & Research Company LLC that seeks capital appreciation by investing primarily in common stocks of companies believed to be undervalued relative to factors such as assets, sales, earnings, or growth potential; focuses on medium-sized companies but also invests substantially in larger or smaller companies; and employs a mid-cap value strategy typically holding 60 to 80 stocks with a portfolio turnover rate of approximately 61%. The fund offers Retail Class shares with a net expense ratio of around 0.80%, daily NAV pricing, and no front-end or deferred loads, targeting individual and institutional investors seeking exposure to undervalued U.S. equities with some non-U.S. stock allocation (approximately 9.54% as of recent data); its portfolio emphasizes sectors like industrials and health care while maintaining diversification across credit quality and sub-industries. Launched on December 30, 1983, with portfolio inception December 31, 1983, the fund is part of Fidelity Investments, a privately held asset manager founded in 1946 and headquartered in Boston, Massachusetts, with global operations across 11 countries. Portfolio manager Matthew Friedman has led the fund since September 14, 2016, supported by Fidelity's research infrastructure for fundamental security selection and disciplined construction aimed at risk-adjusted returns over the long term. As of late 2025, the fund manages net assets of approximately $1.7 billion, with top holdings concentrated in about 14.60% of the portfolio and a year-to-date return of around 6.38%. In the semiannual period ending May 31, 2025, the fund underperformed its Russell Midcap Value Index benchmark due to a cyclical bias amid market volatility from policy shifts and inflation concerns, prompting a more cautious positioning in expensive markets while favoring cheap stocks in health care and industrials. No major acquisitions, funding rounds, partnerships, or structural reorganizations specific to the fund have been announced in the last 1-2 years; ongoing strategic emphasis remains on value-oriented stock selection amid post-election economic uncertainty.